ESO-话题@MedSci - 梅斯（MedSci）

#ESO#

55篇内容 | 2231人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1493276, encodeId=de0b14932e613, content=<a href='/topic/show?id=4223e0260a' target=_blank style='color:#2F92EE;'>#ESO#</a>, objectTitle=RESONATE：伊布替尼治疗伴del17p的rrCLL患者：Ⅱ期开放性多中心研究, objectType=article, longId=116557, objectId=1a0a11655e84, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1a0a11655e84, replyNumber=0, likeNumber=69, createdTime=2017-10-19, rootId=0, userName=hongbochen, userId=30f59021057, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1a0a11655e84, moduleTitle=RESONATE：伊布替尼治疗伴del17p的rrCLL患者：Ⅱ期开放性多中心研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=1a0a11655e84)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1493275, encodeId=3f7114932e523, content=<a href='/topic/show?id=4223e0260a' target=_blank style='color:#2F92EE;'>#ESO#</a>, objectTitle=RESONATE：伊布替尼单药一线治疗CLL患者, objectType=article, longId=116556, objectId=b02f11655638, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b02f11655638, replyNumber=0, likeNumber=98, createdTime=2017-10-19, rootId=0, userName=hongbochen, userId=30f59021057, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b02f11655638, moduleTitle=RESONATE：伊布替尼单药一线治疗CLL患者, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b02f11655638)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1493274, encodeId=f8ea14932e4b6, content=<a href='/topic/show?id=4223e0260a' target=_blank style='color:#2F92EE;'>#ESO#</a>, objectTitle=RESONATE：伊布替尼 vs. 奥法木单抗治疗复发/难治CLL, objectType=article, longId=116555, objectId=bb971165556a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bb971165556a, replyNumber=0, likeNumber=70, createdTime=2017-10-19, rootId=0, userName=hongbochen, userId=30f59021057, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bb971165556a, moduleTitle=RESONATE：伊布替尼 vs. 奥法木单抗治疗复发/难治CLL, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=bb971165556a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1493273, encodeId=178714932e305, content=<a href='/topic/show?id=4223e0260a' target=_blank style='color:#2F92EE;'>#ESO#</a>, objectTitle=欧洲卒中组织(ESO)关于无活动能力的急性缺血性卒中患者静脉血栓栓塞的预防指南（翻译版）, objectType=article, longId=110759, objectId=3ace110e59c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3ace110e59c6, replyNumber=0, likeNumber=87, createdTime=2017-08-26, rootId=0, userName=hongbochen, userId=30f59021057, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3ace110e59c6, moduleTitle=欧洲卒中组织(ESO)关于无活动能力的急性缺血性卒中患者静脉血栓栓塞的预防指南（翻译版）, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=3ace110e59c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1493272, encodeId=a95e14932e2fc, content=<a href='/topic/show?id=4223e0260a' target=_blank style='color:#2F92EE;'>#ESO#</a>, objectTitle=2016 ESO指南：无活动能力急性缺血性卒中患者静脉血栓栓塞的预防, objectType=article, longId=86892, objectId=0c29868925a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0c29868925a, replyNumber=0, likeNumber=53, createdTime=2017-01-08, rootId=0, userName=hongbochen, userId=30f59021057, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0c29868925a, moduleTitle=2016 ESO指南：无活动能力急性缺血性卒中患者静脉血栓栓塞的预防, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0c29868925a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1493271, encodeId=607714932e1b4, content=<a href='/topic/show?id=4223e0260a' target=_blank style='color:#2F92EE;'>#ESO#</a>, objectTitle=Diabetes Care：降脂药volanesorsen能改善糖尿病患者的血糖控制, objectType=article, longId=71828, objectId=afe0e18283d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=afe0e18283d, replyNumber=0, likeNumber=69, createdTime=2016-07-01, rootId=0, userName=hongbochen, userId=30f59021057, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=afe0e18283d, moduleTitle=Diabetes Care：降脂药volanesorsen能改善糖尿病患者的血糖控制, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=afe0e18283d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1493270, encodeId=df3414932e02a, content=<a href='/topic/show?id=4223e0260a' target=_blank style='color:#2F92EE;'>#ESO#</a>, objectTitle=Magn Reson Med：组织的T1信号在动脉自旋标记测量脑血流量时的影响, objectType=article, longId=67864, objectId=720b6e86434, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=720b6e86434, replyNumber=0, likeNumber=97, createdTime=2016-05-11, rootId=0, userName=hongbochen, userId=30f59021057, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=720b6e86434, moduleTitle=Magn Reson Med：组织的T1信号在动脉自旋标记测量脑血流量时的影响, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=720b6e86434)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1493269, encodeId=97ef149326929, content=<a href='/topic/show?id=4223e0260a' target=_blank style='color:#2F92EE;'>#ESO#</a>, objectTitle=ESO：tPA用于严重卒中患者安全, objectType=article, longId=50322, objectId=24b6503224f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=24b6503224f, replyNumber=0, likeNumber=76, createdTime=2015-05-08, rootId=0, userName=hongbochen, userId=30f59021057, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=24b6503224f, moduleTitle=ESO：tPA用于严重卒中患者安全, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=24b6503224f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1493268, encodeId=46c91493268ca, content=<a href='/topic/show?id=4223e0260a' target=_blank style='color:#2F92EE;'>#ESO#</a>, objectTitle=JCEM：生活方式干预对代谢综合征患者血管胰岛素抵抗的影响（Resolve研究）, objectType=article, longId=41990, objectId=4bb841990b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4bb841990b4, replyNumber=0, likeNumber=63, createdTime=2014-11-02, rootId=0, userName=hongbochen, userId=30f59021057, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4bb841990b4, moduleTitle=JCEM：生活方式干预对代谢综合征患者血管胰岛素抵抗的影响（Resolve研究）, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=4bb841990b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1493267, encodeId=c860149326e59, content=<a href='/topic/show?id=4223e0260a' target=_blank style='color:#2F92EE;'>#ESO#</a>, objectTitle=JACC：新型药物洗脱支架的治疗预后及相关预测因素(RESOLUTE研究）, objectType=article, longId=34006, objectId=c0e434006f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0e434006f4, replyNumber=0, likeNumber=69, createdTime=2014-05-03, rootId=0, userName=hongbochen, userId=30f59021057, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0e434006f4, moduleTitle=JACC：新型药物洗脱支架的治疗预后及相关预测因素(RESOLUTE研究）, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c0e434006f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1493266, encodeId=b12e1493266ba, content=<a href='/topic/show?id=4223e0260a' target=_blank style='color:#2F92EE;'>#ESO#</a>, objectTitle=CIT 2014：冠脉分叉病变RESOLVE评分, objectType=article, longId=32134, objectId=385d32134ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=385d32134ac, replyNumber=0, likeNumber=103, createdTime=2014-03-21, rootId=0, userName=hongbochen, userId=30f59021057, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=385d32134ac, moduleTitle=CIT 2014：冠脉分叉病变RESOLVE评分, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=385d32134ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1493265, encodeId=8b7d1493265e3, content=<a href='/topic/show?id=4223e0260a' target=_blank style='color:#2F92EE;'>#ESO#</a>, objectTitle=CIT 2014：冠脉分叉病变RESOLVE评分, objectType=article, longId=31827, objectId=657b3182e08, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=657b3182e08, replyNumber=0, likeNumber=60, createdTime=2014-03-14, rootId=0, userName=hongbochen, userId=30f59021057, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=657b3182e08, moduleTitle=CIT 2014：冠脉分叉病变RESOLVE评分, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=657b3182e08)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1493264, encodeId=d60d1493264db, content=<a href='/topic/show?id=4223e0260a' target=_blank style='color:#2F92EE;'>#ESO#</a>, objectTitle=Watson公司仿制药Budesonide获FDA批准上市, objectType=article, longId=8584, objectId=24288584e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=24288584e0, replyNumber=0, likeNumber=56, createdTime=2012-08-08, rootId=0, userName=hongbochen, userId=30f59021057, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=24288584e0, moduleTitle=Watson公司仿制药Budesonide获FDA批准上市, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=24288584e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1493263, encodeId=c75c14932631c, content=<a href='/topic/show?id=4223e0260a' target=_blank style='color:#2F92EE;'>#ESO#</a>, objectTitle=AACE 2012：Resolute支架在糖尿病患者中的性能优, objectType=article, longId=6816, objectId=912c681637, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=912c681637, replyNumber=0, likeNumber=80, createdTime=2012-06-07, rootId=0, userName=hongbochen, userId=30f59021057, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=912c681637, moduleTitle=AACE 2012：Resolute支架在糖尿病患者中的性能优, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=912c681637)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1493262, encodeId=b0631493262ea, content=<a href='/topic/show?id=4223e0260a' target=_blank style='color:#2F92EE;'>#ESO#</a>, objectTitle=RESONSE：护士组织协调的预防项目对急性冠脉综合征后心血管风险的影响, objectType=article, longId=2118, objectId=922f21183d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=922f21183d, replyNumber=0, likeNumber=90, createdTime=2010-09-11, rootId=0, userName=hongbochen, userId=30f59021057, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=922f21183d, moduleTitle=RESONSE：护士组织协调的预防项目对急性冠脉综合征后心血管风险的影响, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=922f21183d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ESO

2020-05-29

hongbochen (审核中...)

前往app查看评论内容

#ESO#

RESONATE：伊布替尼治疗伴del17p的rrCLL患者：Ⅱ期开放性多中心研究

2017-10-19

hongbochen (审核中...)

前往app查看评论内容

#ESO#

RESONATE：伊布替尼单药一线治疗CLL患者

2017-10-19

hongbochen (审核中...)

前往app查看评论内容

#ESO#

RESONATE：伊布替尼 vs. 奥法木单抗治疗复发/难治CLL

2017-10-19

hongbochen (审核中...)

前往app查看评论内容

#ESO#

欧洲卒中组织(ESO)关于无活动能力的急性缺血性卒中患者静脉血栓栓塞的预防指南（翻译版）

2017-08-26

hongbochen (审核中...)

前往app查看评论内容

#ESO#

2016 ESO指南：无活动能力急性缺血性卒中患者静脉血栓栓塞的预防

2017-01-08

hongbochen (审核中...)

前往app查看评论内容

#ESO#

Diabetes Care：降脂药volanesorsen能改善糖尿病患者的血糖控制

2016-07-01

hongbochen (审核中...)

前往app查看评论内容

#ESO#

Magn Reson Med：组织的T1信号在动脉自旋标记测量脑血流量时的影响

2016-05-11

hongbochen (审核中...)

前往app查看评论内容

#ESO#

ESO：tPA用于严重卒中患者安全

2015-05-08

hongbochen (审核中...)

前往app查看评论内容

#ESO#

JCEM：生活方式干预对代谢综合征患者血管胰岛素抵抗的影响（Resolve研究）

2014-11-02

hongbochen (审核中...)

前往app查看评论内容

#ESO#

JACC：新型药物洗脱支架的治疗预后及相关预测因素(RESOLUTE研究）

2014-05-03

hongbochen (审核中...)

前往app查看评论内容

#ESO#

CIT 2014：冠脉分叉病变RESOLVE评分

2014-03-21

hongbochen (审核中...)

前往app查看评论内容

#ESO#

CIT 2014：冠脉分叉病变RESOLVE评分

2014-03-14

hongbochen (审核中...)

前往app查看评论内容

#ESO#

Watson公司仿制药Budesonide获FDA批准上市

2012-08-08

hongbochen (审核中...)

前往app查看评论内容

#ESO#

AACE 2012：Resolute支架在糖尿病患者中的性能优

2012-06-07

hongbochen (审核中...)

前往app查看评论内容

#ESO#

RESONSE：护士组织协调的预防项目对急性冠脉综合征后心血管风险的影响

2010-09-11

科室
- - 订阅+
  - 更多科室
工具
服务